Femasys Files 8-K on Feb 28, Details General Reporting Categories

Ticker: FEMY · Form: 8-K · Filed: Feb 28, 2024 · CIK: 1339005

Femasys Inc 8-K Filing Summary
FieldDetail
CompanyFemasys Inc (FEMY)
Form Type8-K
Filed DateFeb 28, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, 8-K

TL;DR

**Femasys filed a routine 8-K on Feb 28, nothing major disclosed.**

AI Summary

Femasys Inc. filed an 8-K on February 28, 2024, reporting under Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The filing indicates a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. The company, based in Suwanee, Georgia, with IRS Employer Identification No. 11-3713499, did not disclose specific financial figures or material events beyond the general reporting categories.

Why It Matters

This filing indicates Femasys Inc. is meeting its regulatory obligations, but without specific disclosures, it offers limited new information for investors.

Risk Assessment

Risk Level: low — The filing is a standard regulatory report with no specific adverse events or material changes disclosed.

Key Players & Entities

  • Femasys Inc. (company) — registrant
  • February 28, 2024 (date) — date of report
  • Suwanee, Georgia (location) — principal executive offices
  • 11-3713499 (other) — IRS Employer Identification No.
  • 001-40492 (other) — Commission File Number

FAQ

What is the purpose of this 8-K filing by Femasys Inc.?

The 8-K filing by Femasys Inc. is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting under Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits.

When was the earliest event reported in this 8-K filing?

The date of the earliest event reported in this 8-K filing is February 28, 2024.

What is the address of Femasys Inc.'s principal executive offices?

Femasys Inc.'s principal executive offices are located at 3950 Johns Creek Court, Suite 100, Suwanee, Georgia 30024.

What is Femasys Inc.'s Commission File Number?

Femasys Inc.'s Commission File Number is 001-40492.

What is the telephone number for Femasys Inc.?

The telephone number for Femasys Inc. is (770) 500-3910.

Filing Stats: 601 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2024-02-28 09:16:54

Key Financial Figures

  • $0.001 — ich registered Common Stock, par value $0.001 per share FEMY The Nasdaq Stock Mar

Filing Documents

01

Item 7.01 Regulation FD Disclosure On February 28, 2024, Femasys Inc. (the "Company") posted on its website an updated slide presentation, which is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein. Representatives of the Company will use the presentation in various meetings with investors, analysts and other parties from time to time. The information furnished in this Item 7.01 and Exhibit 99.1 attached hereto is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, except as may be expressly set forth by specific reference in such filing. The Company expressly disclaims any obligation to update or revise any of the information contained in the corporate presentation.

01

Item 8.01 Other Events On February 28, 2024, Femasys Inc. (the "Company") issued a press release announcing FemaSeed FDA clearance brings timely access to a first-line infertility treatment option as an alternative to IVF. A copy of the press release is being furnished as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated herein by reference.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Femasys Inc. Corporate Presentation dated February 28, 2024 99.2 Press Release of Femasys Inc. dated February 28, 2024

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Femasys Inc. By: /s/ Kathy Lee-Sepsick Names: Kathy Lee-Sepsick Title: Chief Executive Officer Date: February 28, 2024

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.